Instructions to authors

Abstracts for communications can be submitted until Sunday, June 15, at 11:59 PM (Paris time) at the latest.

AUTHORS

Creating a user account is mandatory to submit an abstract. Authors of communications will be notified by email about the acceptance or rejection of their abstract(s) in September 2025.

A UNIQUE contact email is required for EACH of your co-authors. Do not reuse the same email address for multiple co-authors.

The full first and last names of the authors must be entered in lowercase, except for the initials, for all authors. Only the initial of the first name of each author is to be provided, listed after the last name (e.g., Dupont J.).

WRITING INSTRUCTIONS

ATTENTION: No abstract submitted in any other form will be accepted (no email submissions). Only one submission per work is allowed. Duplicate abstracts will be removed.

Abstracts must be written exclusively in French or English. Titles must be written in both English and French. All abbreviations, acronyms, etc., must be explained.

Authors are reminded to pay particular attention to the writing of the abstract, as the writing quality contributes to the pre-selection of the chosen works.

CONTENT

ATTENTION: The abstract must be anonymized and must not contain any author names or work locations (neither in the title nor in the body of the text).

The title (maximum 255 characters, including spaces) should not be written entirely in uppercase letters. It must be informative and clearly reflect the content of the abstract. It must be identical in the abstract and in the final communication.

Communications must be original and must not have already been presented at another conference.

The body of the abstract is limited to 42 lines, or approximately 500 words, including spaces, and must be structured in 4 paragraphs:

• Introduction (mandatory)
• Materials and Methods (mandatory)
• Results (mandatory)
• Discussion / Conclusion (mandatory)

There is no option to include images or tables.

Any health product mentioned (medication, medical device, etc.) must be referred to by its generic name only.

CATEGORIES OF COMMUNICATIONS

Authors select the category in which they wish to submit their work. The jury may, if necessary, modify this choice if it appears to be incorrect.